Table 2 Direct-acting antiviral drug registration in surveyed countries (September 2016)
Country | sofosbuvir | sofosbuvir generic | sofosbuvir/ ledipasvir | sofosbuvir/ ledipasvir generic | daclatasvir | daclatasvir generic | ombitasvir/ paritaprevir/ ritonavir/ dasabuvir (Viekira Pak) | ombitasvir/ paritaprevir/ ritonavir | dasabuvir | simeprevir | asunaprevir | narlaprevir | boceprivir | telaprevir |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Armenia | Yes | Yes | ||||||||||||
Azerbaijan | Yes | pending | Yes | Yes | Yes | |||||||||
Belarus | Yes | Yes | Yes | |||||||||||
Georgia | Yes | Yes | pending | Yes | Yes | |||||||||
Kazakhstan | pending | Yes | Yes | Yes | Yes | |||||||||
Kyrgyzstan | Yes | Yes | Yes | pending | ||||||||||
Moldova | Yes | Yes | Yes | Yes | Yes | Yes | ||||||||
Russia | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||||||
Tajikistan | Yes | |||||||||||||
Ukraine | Yes | Yes | Yes | pending | Yes | Yes | Yes | Yes | Yes | Yes | ||||
Uzbekistan | Yes | humanitarian | Yes |